MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma
Figure 2.MND1 expression is association with clinicopathological characteristics in patients with KIRC. Increased MND1 expression was significantly with (A) Gender, (B) Grade, (C) Stage, (D) Tumor size, (E) Metastasis and (F) Node.